How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

How to Test Human-Specific Combination Immunotherapies In Vivo

Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

Organoid Models of Tumor Immunology: Trends in Immunology

Pharmaceutics, Free Full-Text

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives

Targeting Tumor-Associated Antigens and Tumor-Specific Antigens

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine: Molecular Therapy - Methods & Clinical Development